Similar Articles

The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis

Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur

DOI: 10.46497/ArchRheumatol.2023.9636

Issue: Volume 38 - Issue 2 - June 2023
1184 1059

Analysis of risk factors for the progression and prognosis of connective tissue disease-associated interstitial lung disease

Ting Zhao, Fu-an Lin, Hongpu Chen

DOI: 10.46497/ArchRheumatol.2023.9602

Issue: Volume 38 - Issue 2 - June 2023
1200 1080

Clinical association study on the matrix metalloproteinase expression in the serum of patients with connective tissue disease complicated with interstitial lung disease

Hong Chen*, Jun Tang*, Juhua Liang, Dan Huang, Chunfeng Pan, Sha Liu, Xiuri Du, Liju Tao

DOI: 10.46497/ArchRheumatol.2023.9547

Issue: Volume 38 - Issue 3 - September 2023
1329 854

Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study

Minna Jiang, Xiaohong Wen, Sisi Xia, Yiqun Guo, Yu Bai

DOI: 10.46497/ArchRheumatol.2024.10418

Issue: Volume 39 - Issue 2 - June 2024
745 555

Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis

Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria

DOI: 10.46497/ArchRheumatol.2024.10199

Issue: Volume 39 - Issue 2 - June 2024
1701 1240